Novos own data show its obesity-care sales up 56% and global obesity drug demand up 119%
Integrative practitioners may recommend antioxidant IV drips, ozone therapy, or personalized supplement regimens
they say nothing about what months of exposure would do
Tirzepatide, the active ingredient in Zepbound and Mounjaro, is part of new class of medications used to treat obesity and diabetes that have skyrocketed in popularity, driving shortages and leading some people to use versions made by compounding pharmacies
With the rise in popularity of GLP-1 medications like semaglutide and tirzepatide, alongside traditional options like phentermine, many individuals are curious about the potential benefits and risks of using these drugs in tandem
Clinical trial protocols and obesity-medicine guidance generally evaluate GLP-1 medications alongside nutrition, physical activity, and ongoing medical supervision rather than as standalone interventions